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Abstract
An increasing number of studies indicate air pollutants infiltrate into the brain. We 
aimed to find the association of cumulative air pollution exposure in the main body of 
primary brain tumor: glioblastoma (GBM). In this double-cohort, retrospective analy-
sis study with a protocol, we compared the health effect of air pollution on the GBM 
patients from the SEER (Surveillance, Epidemiology, and End Results Program) in 
27 U.S. counties from 10 states and GBM patients of Severance cohort of Korea. 
From 2000 to 2015, 10621 GBM patients of the SEER were individually evaluated 
for the cumulative average exposure for each pollutant, and 9444 (88.9%) mortality 
events were reported. From 2011 to 2018, 398 GBM patients of the Severance with 
the same protocol showed 259 (65.1%) mortality events. The multi-pollutant models 
show that the association level of risk with CO is increased in the SEER (HR 1.252; 
95% CI 1.141-1.373) with an increasing linear trend of relative death rate in the spline 
curve. The Severance GBM data showed such a statistically significant result of the 
health impact of CO on GBM patients. The overall survival gain of the less exposure 
group against CO was 2 and 3 months in the two cohorts. Perioperative exposure to 
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1 |  INTRODUCTION
Accumulation of evidence shows the air pollutants infiltrate 
into the brain, changes the genetic (or epigenetic) status of 
DNA, or may deteriorate oligodendrocytes.1–4 Thus, we hy-
pothesized that the mortality of brain tumor patients might be 
associated with air pollution.5
We focused on the glioblastoma (GBM) patients who are 
classified as the most vulnerable group among the brain tumor 
patients.6 GBM is one of the devastating primary tumors of 
the brain with the median survival about 11 to 30 months.6–8 
These patients suffer from the rapid progression of the dis-
ease, and the patients are prone to stay in the hospital after 
the surgical operation.9 And after they are discharged from 
the hospital, the trip of the patient is limited by the severity, 
emotional distress, brain dysfunction, or comorbidity from 
the disease.10
World health organization (WHO) provide a general 
guideline on the exposure limit on the particulate matters 
(PM10 and PM2.5), carbon monoxide (CO), ozone (O3), nitric 
oxide (NO2), and sulfur oxide (SO2) for the general popula-
tion with the potential health effect.11,12 However, it is still 
uncertain whether these general recommendations can be uti-
lized for the risk stratification of brain tumor patients.
We aimed to find whether an exposure level within a 
specific time-window to ambient air pollution is associated 
with the clinical course of GBM. We applied the result of the 
exploratory step to the protocol-based retrospective observa-
tional analysis of two cohorts: the Severance cohort (Korea) 
and the SEER (Surveillance, Epidemiology, and End Results 
Program, United States) database of GBM to verify our hy-
pothesis that whether the mortality of GBM is associated 
with specific air pollutant.
2 |  MATERIAL AND METHODS
2.1 | Study design and data sources
In this protocol-based retrospective observational study, we 
analyzed the GBM cohort of the Severance hospital and the 
SEER cohort (Table 1, Supporting information Section A). 
Air pollutants (PM10, PM2.5, PM2.5-10, O3, CO, SO2, and NO2) 
data were used for calculation of the individual cumulative 
exposure for the specified time-window.13,14 According to 
the recommendation of the institutional review board and 
the SEER data use agreement; we anonymized and analyzed 
the gathered data to protect the privacy of patients. We ex-
cluded the patients from the analysis if more than 30% of 
exposure data is missing for each pollutant. In line with the 
WHO criteria of the recommended exposure for the air pol-
lutants, we created the cumulative average exposure models 
for this study and the perioperative exposure model based on 
the exploratory step (Supporting information Figure C1). The 
global minimum of the Euclidean distance between each pa-
tient and the closest local air pollution monitoring station was 
used to allocate patients to the nearest station. All the analysis 
included in this study includes patients within the 10 km (six 
miles) distance from the monitoring station to the residential 
area of the patients after the distance analysis (Supporting in-
formation Figure D1–6, Figure E6–10). Exposure details and 
further analysis for each cohort are provided in the appendix.
2.2 | The protocol-based procedures
Single-pollutant model analysis of comparing the Severance 
cohort and the SEER cohort was performed (Table 2). 
Primary analysis harmonized the criteria of selecting patients 
by the distance from the monitoring stations and the adjust-
ing variables between the different cohorts. The periopera-
tive exposure was estimated by the 1-month exposure of the 
month that the diagnosis of GBM was made in the hospital 
or the month of surgical operation. Subgroup analysis by the 
molecular markers was performed in the Severance cohort, 
as neither IDH (Isocitrate dehydrogenase) mutation status 
and MGMT (O-6-methylguanine-DNA methyltransferase) 
promoter methylation status were available in the SEER 
cohort (Table 2). Multi-pollutant models included the same 
adjusting factors as the single-pollutant models (Table 3). 
The sensitivity tests were done excluding one factor from 
the multivariate-adjusted models (Supporting information 
Figure E1–5). The cause-of-death analysis and other suscep-
tibility tests were studied in the SEER cohort.
2.3 | Primary outcomes
We used the overall survival mortality as the primary outcome 
in the analysis. We gathered the mortality data of Severance 
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cohort from the cancer registry of Severance hospital, which 
records the survival of oncology patients from death certifi-
cates, national health insurance survival data, and electronic 
medical records. The SEER database provided the mortality 
data and the cause of deaths with the registration and accept-
ance of the agreement form.
2.4 | Statistical analysis
Cox proportional-hazards regression was used to estimate 
hazard ratios and 95% confidence intervals (CIs) for the time 
to the first mortality event in the GBM patients associated 
with an elevation of 10  μg per cubic meter in the level of 
cumulative average exposure to particulate matters (PM10, 
PM2.5, and PM2.5-10) for both cohorts. Other pollutants were 
assessed with the harmonized units between the cohorts (ppm 
for CO; ppb for O3, SO2, and NO2). To estimate the con-
centration-response association of exposure and the relative 
death rate, we fit a penalized spline curve (degree of free-
dom = 4). Cyclic patterns of air pollutants were calculated 
using the autocorrelation method.
3 |  RESULTS
3.1 | The air pollutants of two cohorts.
We evaluated the baseline characteristics of air pollution over 
the years of Korea and the United States. Overall, the level 
of PM10 decreased in recent years (Supporting information 
Section Figure B.1–4). The PM10 shows a seasonal cyclic 
pattern with a peak in different seasons. CO shows a decreas-
ing trend in Korea and the United States with cyclic seasonal 
pattern (Supporting information Section Figure B.5–6). The 
dimensional reduction technique revealed PM10, O3, and CO 
are relatively independent in the two databases (Figure 1), 
allowing us to compare the health impact of these pollutants.
3.2 | The discovery step of the 
Severance cohort
Before the primary analysis, we examined the discovery step 
to find the time-window from the date of operation whether 
the cumulative average of specific air pollutants affect the 
survival of the GBM patients (Supporting information A.4). 
We implemented long-term and short-term time-windows 
and compared the results in the preoperative (in the resi-
dential address of patients) and the postoperative exposure 
window (in the hospital). We made Cox hazard models that 
adjust for age, sex, and molecular markers (IDH and MGMT 
promoter methylation) and visualized the results with differ-
ential time-windows (Supporting information Figure C3–10). 
The elevated exposure level to PM10, CO, and sulfur dioxide 
was associated with the poor overall survival of the GBM pa-
tients (Supporting information Table C1). The preoperative 
exposure shows the difference of median survival with PM10 
and CO (Supporting information Figure C2).
From this finding, we hypothesized that the surrogate es-
timate of the 1-month perioperative exposure might replicate 
the risk elevation pattern in the Severance cohort. Thus, the 
method can be applied for the SEER database (Supporting 
information Figure C1).
3.3 | The demographics of the two cohorts
The characteristics of the two cohorts for the primary anal-
ysis share the diagnosis of GBM, age (older than 19 years), 
F I G U R E  1  PCA plot of air pollutants in the protocol-based analysis. The individual exposure data of GBM patients for the cohort of the 
Severance and the SEER database. PCA: The principal component analysis, Dim: Dimension, GBM: Glioblastoma, ppm: Parts per million, ppb: 
Parts per billion, PM: Particulate matter, FRM/FEM: A federal reference method and a federal equivalent method of measuring PM2.5, CO: Carbon 
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and the distance range within the 10 km (six miles) from 
the air monitoring stations (Table 1). The mean age of di-
agnosis is younger in the Severance cohort (56.7 vs 64.0). 
Male patients consisted of two-third of the patients in both 
groups (60.8% vs 58.9%). For both cohorts, the pollut-
ant models were adjusted by age, sex, surgical sequence 
(relative to radiotherapy), type of radiation, the status of 
chemotherapy, and race (different races were included and 
adjusted in the SEER model, not in the Severance models). 
The diagnosis of all patients of Severance cohort was from 
the surgical confirmation of the pathologic slides (100%), 
and the diagnostic methods of the SEER include surgical 
diagnosis (9778, 91.8%), clinical diagnosis (747, 7.0%), 
and other methods (116, 1.0%). Further details of the 
cohort are described in Table D1,2 (Severance) and Table 
E1,2 (SEER) of Supporting information.
3.4 | Protocol-based retrospective analysis 
with the perioperative exposure model
We built a protocol that can validate our hypothesis in the 
Severance cohort and the SEER cohort (Supporting informa-
tion A.10). Individual-level exposure was estimated for each 
pollutant in the perioperative period (1-month exposure when 
the diagnosis was made). As the molecular marker IDH mu-
tation status was available for Severance GBM patients, we 
compared the risk of air pollution effect on all 398 patients 
considering the marker, while not in the SEER cohort which 
lacks the molecular marker information (Table 2).
3.5 | Elevated mortality risk by the CO and 
PM10 exposure
In the single-pollutant models, CO was the only one air 
pollutant statistically significant (Table 2). The level of 
hazard ratio was attenuated in the SEER cohort (HR 1.075; 
95% CI 1.006-1.148) than the Severance cohort (HR 
3.034; 95% CI 1.483-6.206). Elevated risk by the CO re-
mained and more accentuated in the IDH-mutant patients 
(HR 91.225; 95% CI 1.032-8066.238, 9.6% of total GBM 
patients).
PM10 was found to be associated with the elevated risk in 
the subgroup of Severance cohort (HR 1.095; 95% CI 1.007-
1.192, Table 2) with IDH-wild-type GBM which comprises 
90.3% of GBM as well as in the SEER cohort (HR 1.044; 
95% CI 1.025-1.063, Table 2). The association of health risk 
from the ambient CO was also found in the multi-pollutant 
model (Table 3). And the multi-pollutant models showed 
a dose-response effect with the relative death rate with CO 
(Figure 2).
The health effect of PM10, O3, and SO2 were not consis-
tent over the two different cohorts (Table 2 and 3). While the 
SEER cohort shows the elevated risk from O3 in the GBM 
(HR 1.004; 95% CI 1.002-1.006), the Severance cohort does 
not show such a result (Table 2). SO2 was associated with 
the elevated in the all GBM of Severance cohort (HR 1.09; 
95% CI 1.026-1.159) and not consistent in the SEER cohort 
(Table 2).
From the primary analysis of the perioperative exposure 
model, we selected PM10 and CO as the possible risk asso-
ciated air pollutant in the GBM. We assessed the association 
in a larger data set of Severance cohort that includes non-
GBM samples in the same study period (Supporting infor-
mation Figure D1). The Kaplan–Meier curve of GBM shows 
the median survival of PM10 was not significantly different, 
T A B L E  1  The clinical characteristics of patients
Severance cohort SEER cohort
Patients (n = 398) (n = 10 621)




CO (ppm) 0.5 ± 0.1 0.5 ± 0.3
Age 56.7 ± 13.5 64.0 ± 13.9
Sex
Male 242 (60.8%) 6 255 (58.9%)
Female 156 (39.2%) 4 366 (41.1%)
Race
Asian 398 (100%) 838 (7.9%)
White 0 (0%) 7 390 (69.6%)
Hispanic 0 (0%) 1 789 (16.8%)
Black 0 (0%) 571 (5.3%)
Others 0 (0%) 33 (0.3%)
Surgery
Yes 398 (100%) 7 632 (71.9%)
No 0 (0%) 2 989 (28.1%)
Chemotherapy
Yes 325 (81.6%) 5 655 (53.2%)
No 73 (18.3%) 4 966 (46.7%)
Radiation mode
Adjuvant radiation 335 (84.2%) 5 592 (52.6%)
No 63 (15.8%) 5 029 (47.4%)
Radiation
Beam radiation 361 (90.7%) 6 970 (65.6%)
No 37 (9.3%) 3 651 (34.4%)
Data are n (%) and mean with standard deviation. Diagnosis of all patients is 
made as glioblastoma.
PM10: Particulate matter with an aerodynamic diameter less than 10 µm, CO: 
Carbon monoxide, ppm: Parts per million.
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and that of CO was significant (PM10, 16  months for both 
groups, p = 0.16; CO, 15 vs 18 months, Log-rank p = 0.011). 
The survival of non-GBM was not associated with the above 
pollutants.
3.6 | Cause of death analysis in the 
SEER cohort
We also did a cause-of-death analysis in the SEER co-
hort (Figure 3). PM10 showed associations with the over-
all cause, brain cause, and cardiovascular cause mortality 
(that includes the cerebrovascular cause death) of GBM. 
CO showed associations with the overall and the cardio-
vascular cause mortality (that includes cerebrovascular 
cause death). Ozone showed overall, brain, and pulmo-
nary cause mortality, which may be consistent with the 
prior result.15 Additionally, PM2.5-10 was associated with 
an  elevated risk in the cardiovascular mortality of GBM 
(Figure 3).2,16 More details are provided in Table E3 of 
Supporting Information.
3.7 | Sensitivity and susceptibility analysis
The sensitivity test of the SEER shows that the statistical sig-
nificance of PM10 and O3 remained stable with the exclusion 
of a variable from the main full-adjusted model (Supporting 
information Figure E1,E3). The models of CO and SO2 
revealed that the associations vary by the sensitivity test 
(Supporting information Figure E2,E4).
The susceptibility shows the elevated risk of PM10 and 
CO remained stable in the by sex, radiation-surgery se-
quence, and chemotherapy (Supporting information Table 
E4). Older patients were more vulnerable to exposure to CO, 
and younger patients were associated with PM10. Patients 
with beam radiation were not associated with the elevated 
risk of CO exposure (HR 1.047; 95% CI 0.966-1.136).
We also assessed other factors, such as the location of 
patients, the year of diagnosis, and the month of diagnosis. 
Inequal population among states was found in the subgroup 
analysis: 73% of patients were from the California state, and 
the number of patients from nine states were without associ-
ation with these two air pollutants when combined as a group 
(Supporting information Table E5). When the patients are 
spread to 16 years, there was no association in the CO with the 
elevated risk of mortality, while PM10 shows an intermittent 
association (Supporting information Table E6). The month of 
diagnosis also shows no consistent pattern of association with 
PM10 and CO (Supporting information Table E7).
3.8 | Difference in the median survival
In the discovery step, the estimated survival benefits of PM10 
and CO were three  months each (Supporting information 
Figure C2). The protocol-based Severance perioperative ex-
posure model shows the statistical significance remained by 
the exposure level against CO with three months of survival 
gain in the lower exposure group of GBM (Supporting infor-
mation Figure D1). The SEER data show that the estimated 
benefit of the low exposure group of PM10 and CO shows 
two  months of survival gain in the lower exposure group 
(Supporting information Figure E12).
4 |  DISCUSSION
Carbon monoxide (CO) is a continuing problem for the global 
society.17–19 In addition to the previously known acute high-
level exposures,17 our study revealed that chronic ambient-
level exposure against CO is associated with a significantly 
F I G U R E  2  Therelative death rate of the multi-pollutant models in the SEER cohort. The estimates of both graphs were adjusted for age, sex, 
race, radiotherapy type, surgery to radiation sequence, and the status of chemotherapy. PM10: particulate matter with an aerodynamic diameter less 
than 10 µm, CO: carbon monoxide, ppm: parts per million.
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deteriorated survival of patients. In this retrospective double-
cohort observational study, we validated the perioperative 
exposure models of individual patients of GBM, and we asso-
ciated the risk of overall survival with the level of exposure. 
We found that ambient-level CO showed the most significant 
adverse health effect, suggesting a chronic low-level expo-
sure can shorten the survival of GBM patients. While the 
impact of CO in the SEER cohort was relatively attenuated 
than the Severance cohort, the hazard ratio of cardiovascu-
lar death shows more elevated risk (Figure 3) as well as in 
the multi-pollutant model (Table 3). The brain tumor mortal-
ity was reported as not affected by the air pollution in the 
Cancer Prevention Study-II.20,21 However, we found the first 
association of CO with the survival of GBM patients in the 
double-cohort setting.
The air pollutant, CO, may be interpreted as the factor 
that influences the survival of the patient.22 it is still un-
certain whether the air pollutant affected the nonbiological 
factors, the baseline patient condition, other organs such 
as heart, other factor/cells in the bloodstream, cancer-or-
igin-related cell (such as oligodendrocyte progenitor cells 
[OPC]), the tumor cell itself, the necrotic portion of the 
disease, or its surrounding cells.23,24 We speculate that if 
CO can deteriorate OPCs,3 the delayed neurological se-
quelae-associated effects of CO can be exaggerated or ac-
celerated in the OPC-related GBM.25,26
The limitations include the characteristics of this study, 
methodology, included patients, behavioral differences, 
and migration issues. As this is an observational study, our 
result shows a preliminary example of the association of 
the air pollutant and not address the causality of the phe-
nomenon. The cumulative average method is a well-known 
method with known limitations in the field of industrial 
epidemiology and pharmaceutical epidemiology.14,27,28 To 
manage the issue of long-term exposure, we assessed the 
extended timeframes of differential windows up to nearly 
1800 days prior to the surgery, and we found that the sea-
sonal variation may bias the results (Supporting informa-
tion Section B or Figure C3–5). The spatial resolution of 
10 km (six miles) also restricted the population of GBM 
of both cohorts (Supporting information Figure D2–6). 
Especially, the SEER cohort from 42 303 to 10 621 for 
the limited number of air monitoring station with 73% 
of the population in California (Supporting information 
Figure E6-E10). The small number of patients that does 
not include all population of GBM of Korea and the United 
T A B L E  2  The hazard ratio of single-pollutant models with the increment of a single unit.
Models
Severance Model 
1a p Severance Model 2b p Severance Model 3c p SEER Model p
Exposure N = 398 N = 361 N = 37 N = 10 621
PM10 (10 µg/m
3) 1.078 (0.994–1.171) 1.095 (1.007–1.192) 0.034 0.887 (0.586–1.341) 1.044 (1.025–1.063) <0.0001
CO (1 ppm) 3.034 (1.483–6.206) 0.0023 2.745 (1.336–5.642) 0.0059 91.225 (1.032–8066.238) 0.048 1.075 (1.006–1.148) 0.031
Ozone (1 ppb) 0.994 (0.982–1.006) 0.996 (0.984–1.009) 0.99 (0.933–1.05) 1.004 (1.002–1.006) <0.001
SO2 (1 ppb) 1.09 (1.026–1.159) 0.0057 1.09 (1.024–1.159) 0.0066 1.06 (0.685–1.64) 0.990 (0.983–0.998) 0.014
NO2 (1 ppb) 1.01 (0.999–1.021) 1.011 (0.999–1.022) 0.992 (0.941–1.046) 0.998 (0.996–0.999) 0.032
All models are adjusted by age, sex, radiation method, radiation surgery sequence, chemotherapy status, and race. Bold indicates significant values (p < 0.05).
PM: particulate matter, CO: carbon monoxide, O3: ozone, SO2: sulfur dioxide, NO2: nitrogen dioxide, ppm: parts per million, ppb: parts per billion.
aAll GBM patients included for the Cox model. 
bIDH-wild-type GBM model. 
cIDH-mutant GBM model. 
Severance Cohort p SEER Cohort p
Exposure N = 398 N = 10 621
PM10 (10 µg/m
3) 0.994 (0.896 –1.103) 1.004 (1.002–1.006) <0.0005
CO (1 ppm) 2.874 (1.040 –7.944) 0.041 1.252 (1.141–1.373) <0.0001
Ozone (1 ppb) 1.006 (0.99–1.022) 1.003 (1.000–1.005) 0.023
SO2 (1 ppb) 1.065 (0.985–1.151) 0.991 (0.983–0.999) 0.032
NO2 (1 ppb) 1 (0.984–1.017) 0.994 (0.991–0.996) <0.0001
The models are adjusted by all the included pollutant levels, age, sex, race, radiation method, radiation surgery 
sequence, chemotherapy status, and race. Bold indicates significant values (p < 0.05).
PM: Particulate matter, CO: Carbon monoxide, O3: Ozone, SO2: Sulfur dioxide, NO2: Nitrogen dioxide, ppm: 
Parts per million, ppb: Parts per billion.
T A B L E  3  Hazard ratio of multi-
pollutant models with the increment of a 
single unit
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States (Based on the U.S. population in 2015, about 15% of 
GBM were included for this study), and with the most pa-
tients from California (Supporting information Table E5). 
As we did not consider the humidity and temperature of 
each region for the method we applied, the confounding ef-
fect of climate was not examined in this study. Considering 
the seasonal pattern of Korea and California, the winter 
season might be associated with the mortality pattern. The 
behavioral difference between Korean and U.S. patients 
should be considered when interpreting the results.9,29 Due 
to Korean national health insurance coverage, there is an 
overall difference in the patient behavior of the length of 
stay in the hospital after the brain tumor operation: Korean 
stays longer than the U.S. patients (19 days vs 3-6 days).9,30 
Migration rate should have less affected the outcome of 
this study than other long-term studies.21,22 The lower mi-
gration rate of the census data shows that about 95% of 
patients lived in the same county in the last year in the 
United States (Supporting information Table E1,E2). And 
we should mention that there are other unknown factors 
inherent in our study that should have influenced our 
results.
In the design process for this study with STROBE guidelines, 
we hypothesized that the perioperative exposure could be used to 
show the difference in the survival in the patients based on the dis-
covery data (Supporting information A.10). Our first aim of find-
ing a pollutant was achieved with CO from both cohorts and not 
with PM10 in the Severance cohort. Our second aim of quantify-
ing the health effect on the overall survival was achieved: Even the 
two databases of Severance and the SEER show a relatively robust 
risk pattern of CO, the difference of median survival by the expo-
sure level is three months in the Severance cohort and two months 
in the SEER database (Supporting information Figure E12). This 
double-cohort,  retrospective observational result of an association 
from the air pollutants found a major subset of brain tumor pa-
tients who are more vulnerable to chronic CO exposure.20,21
In summary, we found that the elevated exposure level to 
CO is associated with the elevated risk of mortality of GBM 
patients in this double-cohort retrospective study. Even the 
survival gain is 2 to 3 months, considering the devastating 
F I G U R E  3  Thesingle-pollutant models and the cause of death in the SEER database. These models were adjusted by age, sex, race, surgical 
sequence to radiation, radiation type, and chemotherapy status. PM: Particulate matter, CO: Carbon monoxide, O3: Ozone, SO2: Sulfur dioxide, 
NO2: Nitrogen dioxide.
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short survival of glioblastoma and recent findings on the 
adverse health effect on the brain, this association warrants 
further biological study.
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